ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,616Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 663

$718K Total Retail Price of All Prescriptions

Rank: 23 out of 663

457 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

17% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,704 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
AMLODIPINE BESYLATE 329 295 1 5
LIDODERM 292 283 2 67
SIMVASTATIN 272 243 3 1
LEVOTHYROXINE SODIUM 259 214 4 3
METFORMIN HCL 227 211 5 9
OMEPRAZOLE 215 172 6 4
RANITIDINE HCL 186 178 7 31
ZOLPIDEM TARTRATE 185 125 8 16
TRIAMTERENE-HCTZ 176 155 9 42
ALENDRONATE SODIUM 175 154 10 15
HYDROCODONE-ACETAMINOPHEN 168 80 S3 11 6
ACETAMINOPHEN-CODEINE 159 149 S3 12 158
LISINOPRIL 156 133 13 2
TAMSULOSIN HCL 144 135 14 24
HYDROCHLOROTHIAZIDE 141 123 15 12
NEXIUM 138 102 16 43
AZITHROMYCIN 123 89 17 64
FLUTICASONE PROPIONATE 118 86 18 27
ATENOLOL 118 118 18 10
ATORVASTATIN CALCIUM 108 100 20 13
OXYCODONE HCL 107 0 S2 21 41
GABAPENTIN 97 80 22 20
METOPROLOL SUCCINATE 94 87 23 25
SULINDAC 87 78 24 248
MELOXICAM 75 57 25 61
MORPHINE SULFATE ER 74 0 S2 26 51
ZETIA 74 41 26 80
CELEBREX 73 66 28 85
DONEPEZIL HCL 73 73 28 40
GLIPIZIDE 73 67 28 29
METOPROLOL TARTRATE 69 65 31 11
CLOBETASOL PROPIONATE 69 54 31 221
FLUOXETINE HCL 67 40 33 32
LOSARTAN POTASSIUM 67 60 33 14
TRIAMTERENE-HYDROCHLOROTHIAZID 63 49 35 49
CARISOPRODOL 63 0 R 35 134
CLOTRIMAZOLE-BETAMETHASONE 63 55 35 164
DIOVAN HCT 58 51 38 115
LOVASTATIN 57 55 39 30
PROAIR HFA 57 21 39 33
JANUVIA 55 35 41 78
WARFARIN SODIUM 53 53 42 8
DIOVAN 53 51 42 59
FUROSEMIDE 53 39 42 7
CARVEDILOL 52 52 45 47
LIPITOR 52 45 45 72
CIPROFLOXACIN HCL 50 45 47 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.